Rutgers, Carestream Collaborate on New Products, Knowledge Exchange | GenomeWeb

NEW YORK (GenomeWeb News) – Rutgers University and Carestream Molecular Imaging today announced the signing of a two-year collaborative agreement that provides the university with a PET/CT imaging platform, computer systems, and software.

As part of the deal, Rutgers and Carestream will partner on product awareness, the exchange of scientific knowledge, and new product development. The new Molecular Imaging Center at the university will also serve as a user demonstration site.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.